Having recently completed a series A financing round of up to $40 million, Cirius Therapeutics announced on 5/2/2018 that it has reached its enrollment target in its Phase 2b EMMINENCE trial for... read more
Having recently completed a series A financing round of up to $40 million, Cirius Therapeutics announced on 5/2/2018 that it has reached its enrollment target in its Phase 2b EMMINENCE trial for... read more
Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that it has submitted an Investigational New... read more
Foundation Medicine, Inc. (NASDAQ:FMI) today announced a comprehensive gene expression profiling (GEP) program to support precision oncology clinical research and development. This initiative,... read more
NeoImmuneTech (NIT), an immunotherapy drug development company focused on advanced cancer treatments, and its parent company Genexine, have entered into an agreement with Roche to enable studies... read more
Colorectal cancer has a high mortality rate in advanced stages of the disease with few effective therapies. Researchers at the Sidney Kimmel Cancer Center (SKCC) at Jefferson Health show that a... read more